Skip to content
Aperlena

Germany - Radioactive materials - Sale of 7.7 g of Radium-226 for medical applications

Open Contract notice

Key facts

Where
Germany
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
09343000 Radioactive materials
Original language
English
Published
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
500469-2026
Watch this tender

We email you if the deadline moves or a correction is published. Free. Log in

Summary

Machine-generated summary

The European Commission's Joint Research Centre (JRC) in Karlsruhe, Germany, plans to sell approximately 7.7 grams of Radium-226 (Ra-226) from its strategic inventory. The material is intended for medical applications, notably as a source for producing Actinium-225, used in targeted alpha therapy, and other medical radioisotopes such as Lead-212. The sale aims to strengthen the supply chain for medical isotopes amid growing demand and limited supply of Ra-226. Interested parties should consult the full tender documents for participation requirements.

Description

The European Commission, Joint Research Centre (JRC) in Karlsruhe (Germany) plans to sell approximately 7.7 grams of Radium-226 (Ra-226), a valuable resource from its our strategic inventory utilised for cutting-edge research and development in nuclear medical applications. This includes applications in the production of Actinium-225 (Ac-225) for the use of targeted alpha therapy. Following a surge of demand for Ac-225, Ra-226 material serves as a crucial source material for producing it as well as other valuable medical radioisotopes, such as Lead-212 (Pb-212). With a growing demand and limited supply for Ra-226, the JRC Karlsruhe wants to contribute to the medical isotope supply chain. The expertise along with the state-of-the-art assets at JRC Karlsruhe, equips it to contribute effectively to this critical field. This sale is meant to bolster the availability of Ra-226 for medical applications and further the advancement of nuclear medicine.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

More from this buyer

Full buyer profile

3 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Petroleum, fuel & energy - Germany

Company Wins Total awarded Last win
enercity AG 36 €81.0M Sep 2026
N-ERGIE AG 25 €28.0M Sep 2026
Köthen Energie GmbH 17 €17.7M Sep 2026
ENNI Energie & Umwelt Niederrhein GmbH 11 €3.6M Sep 2026
BEW Berliner Energie und Wärme GmbH 11 €82,773 May 2026

Based on 496 awards with a linked company profile over the last 2 years.

Similar tenders

Market context

Avg. open tender · Petroleum, fuel & energy
€13,980,970
4,463 open across Europe right now
Buyer track record on Aperlena
18 notices tracked · 3 awarded
€179,979 in awarded contracts

Never miss a tender like this

64 new notices in Petroleum, fuel & energy in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language